ACET Q2 2018 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$71M

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$14M

Net Income

-$14M

EPS (Diluted)

$-8.80

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

$402,000

Free Cash Flow

$402,000

Stock-Based Comp.

$402,000

Balance Sheet

Total Assets

$129M

Total Liabilities

$12M

Stockholders' Equity

$117M

Cash & Equivalents

$51M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$115M	-100.0%
Gross Profit	$0	$39M	-100.0%
Operating Income	-$14M	$35M	-140.7%
Net Income	-$14M	$25M	-153.6%

Revenue Segments

Human Health

$375M53%

Performance Chemicals

$178M25%

Pharmaceutical Ingredients

$159M22%

Geographic Segments

UNITED STATES

$536M75%

GERMANY

$97M14%

FRANCE

$37M5%

Asia Pacific

$30M4%

NETHERLANDS

$12M2%